Article
Novel use of a selectable fusion gene as an "in-out" marker for studying genetic loss in mammalian cells.
Molecular carcinogenesis - 1 Apr 1995
Trott D A, Cuthbert A P, Todd C M, Themis M, Newbold R F
Abstract excerpt
Recent demonstrations of loss of heterozygosity in a wide variety of human cancers suggest that large multilocus genetic deletions (presumably including tumor suppressor genes) constitute a major class of genetic alteration in human carcinogenesis. Here we show that a bifunctional fusion gene (Hytk), suitable for both positive and negative selection, is an effective marker for studying genetic loss in mammalian...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.